" class="no-js "lang="en-US"> Alon Ben-Noon - Medtech Alert
Friday, September 12, 2025
Alon Ben-Noon

Alon Ben-Noon

About Alon Ben-Noon

Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm which worked and collaborated with many leading pharmaceutical R&D companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. The firm’s diligent employees were pioneers, who paved the way to more efficient and accurate work in the industry, mainly in small biotech companies, while coordinating innovative Drug Development Programs, managing operational activities and involved in business development activities.

MBA and BSc in Industrial Engineering, both from Ben-Gurion University

Related Story

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers Using AI and ML

July 29 2022

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company […]